Integrative transcriptome profiling reveals miR-650 as an oncogenic factor in lung adenocarcinoma through down-regulating MMRN2, ROBO4 and ESAM

Liu, Jun, Liu, Kai, Huang, Chusheng, Qian, Jun, Yang, Yan, Qian, Kai, Ning, Xiangu, Wang, Li, Huang, Yu, Xian, Lei
Molecular & Cellular Toxicology · Springer Nature · 2026-10-01 · DOI: 10.1007/s13273-026-00664-0

Аннотация

Background Lung cancer remains the leading cause of cancer-related mortality worldwide. In this study, we aimed to elucidate the miRNA–mRNA regulatory networks underlying lung adenocarcinoma development. Objective Through the integration of transcriptomic and miRNA profiling data, a miRNA–mRNA regulatory network was systematically constructed and the expression patterns of candidate genes and miRNAs were validated in clinical specimens. The biological implications of this regulatory axis were further investigated in lung adenocarcinoma cells, encompassing its functional effects on proliferation, apoptosis, and invasion in vitro, as well as its impact on tumor growth and metastasis in vivo. Results A unique miRNA–mRNA regulatory module was identified in lung adenocarcinoma through integrated approach of bioinformatics analyses, which involves the up-regulation of miR-650 and the concomitant decrease in its target genes MMRN2, ROBO4, and ESAM. We further demonstrated the critical role of this regulatory axis in driving the aggressive features of lung adenocarcinoma cells, including accelerated cell growth, resistance to cell death, and invasiveness. Furthermore, targeting miR-650 potently impeded tumor growth and metastasis, underscoring the therapeutic potential of this regulatory module. Conclusions The up-regulation of miR-650 and the concomitant down-regulation of its target genes MMRN2, ROBO4, and ESAM collectively contribute to the aggressive phenotype of lung adenocarcinoma cells. Targeting this regulatory axis therefore represents a promising and clinically relevant therapeutic strategy for the management of lung adenocarcinoma patients.

Читать у издателя →

Похожие статьи